AU2006287702A1 - Method for diagnosing infections - Google Patents
Method for diagnosing infections Download PDFInfo
- Publication number
- AU2006287702A1 AU2006287702A1 AU2006287702A AU2006287702A AU2006287702A1 AU 2006287702 A1 AU2006287702 A1 AU 2006287702A1 AU 2006287702 A AU2006287702 A AU 2006287702A AU 2006287702 A AU2006287702 A AU 2006287702A AU 2006287702 A1 AU2006287702 A1 AU 2006287702A1
- Authority
- AU
- Australia
- Prior art keywords
- organism
- antigens
- surface antigens
- test
- map
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 109
- 208000015181 infectious disease Diseases 0.000 title claims description 40
- 239000000427 antigen Substances 0.000 claims description 167
- 102000036639 antigens Human genes 0.000 claims description 167
- 108091007433 antigens Proteins 0.000 claims description 167
- 238000012360 testing method Methods 0.000 claims description 129
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 claims description 104
- 210000002966 serum Anatomy 0.000 claims description 45
- 241001465754 Metazoa Species 0.000 claims description 37
- 244000005700 microbiome Species 0.000 claims description 32
- 239000012530 fluid Substances 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 21
- 238000000527 sonication Methods 0.000 claims description 19
- 238000011282 treatment Methods 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 10
- 241000186359 Mycobacterium Species 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 230000003287 optical effect Effects 0.000 claims description 9
- 238000003260 vortexing Methods 0.000 claims description 7
- 108010032595 Antibody Binding Sites Proteins 0.000 claims description 6
- 238000000684 flow cytometry Methods 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 description 63
- 239000000523 sample Substances 0.000 description 39
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 37
- 201000010099 disease Diseases 0.000 description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
- 238000003745 diagnosis Methods 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 230000002550 fecal effect Effects 0.000 description 25
- 238000002405 diagnostic procedure Methods 0.000 description 19
- 230000035945 sensitivity Effects 0.000 description 17
- 238000002965 ELISA Methods 0.000 description 15
- 239000000284 extract Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 235000013336 milk Nutrition 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 6
- 239000000834 fixative Substances 0.000 description 6
- 230000001524 infective effect Effects 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 208000011231 Crohn disease Diseases 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 208000010711 Cattle disease Diseases 0.000 description 3
- 241000606161 Chlamydia Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000282849 Ruminantia Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000013024 dilution buffer Substances 0.000 description 3
- 244000000013 helminth Species 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000283153 Cetacea Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102000008070 Interferon-gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 241000186367 Mycobacterium avium Species 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 208000026681 Paratuberculosis Diseases 0.000 description 2
- 241000283080 Proboscidea <mammal> Species 0.000 description 2
- 241000606701 Rickettsia Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229940044627 gamma-interferon Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000606750 Actinobacillus Species 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001147657 Ancylostoma Species 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000223836 Babesia Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241001126268 Cooperia Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 241000179197 Cyclospora Species 0.000 description 1
- 241000243990 Dirofilaria Species 0.000 description 1
- 241000223924 Eimeria Species 0.000 description 1
- 241000224431 Entamoeba Species 0.000 description 1
- 241000498256 Enterobius Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000243976 Haemonchus Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- 241000283953 Lagomorpha Species 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000283960 Leporidae Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000428199 Mustelinae Species 0.000 description 1
- 206010062207 Mycobacterial infection Diseases 0.000 description 1
- 241000224436 Naegleria Species 0.000 description 1
- 241000498271 Necator Species 0.000 description 1
- 241001137882 Nematodirus Species 0.000 description 1
- 241001147660 Neospora Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000510960 Oesophagostomum Species 0.000 description 1
- 241000243795 Ostertagia Species 0.000 description 1
- 241000283203 Otariidae Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000283216 Phocidae Species 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000223777 Theileria Species 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000242541 Trematoda Species 0.000 description 1
- 241000243797 Trichostrongylus Species 0.000 description 1
- 241001489151 Trichuris Species 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 208000013184 decreased milk production Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical class OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000003281 pleural cavity Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- -1 tertiary butyrol Chemical compound 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/220,156 | 2005-09-06 | ||
| US11/220,156 US7713715B2 (en) | 2005-09-06 | 2005-09-06 | Method for diagnosing infections |
| PCT/US2006/034287 WO2007030391A2 (en) | 2005-09-06 | 2006-09-05 | Method for diagnosing infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2006287702A1 true AU2006287702A1 (en) | 2007-03-15 |
Family
ID=37830465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006287702A Abandoned AU2006287702A1 (en) | 2005-09-06 | 2006-09-05 | Method for diagnosing infections |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7713715B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1928614A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009507243A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006287702A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615678A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2621485C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007030391A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070062460A1 (en) * | 2005-09-21 | 2007-03-22 | Robert Simer | Swine saliva sampling method |
| JP5697991B2 (ja) * | 2008-02-01 | 2015-04-08 | サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ | 診断的アッセイ |
| DE102008029834A1 (de) * | 2008-06-25 | 2010-01-14 | Justus-Liebig-Universität Giessen | Verfahren zum spezifischen Nachweis von MAP-Antikörpern |
| WO2010010914A1 (ja) * | 2008-07-23 | 2010-01-28 | オリンパス株式会社 | 糞便試料からの核酸回収方法、核酸解析方法及び糞便試料処理装置 |
| US9696304B2 (en) | 2012-01-27 | 2017-07-04 | University Of Tennessee Research Foundation | Methods for detecting a biomarker by alternating current electrokinetics |
| CA2862630A1 (en) | 2012-01-27 | 2013-08-01 | University Of Tennessee Research Foundation | Method and apparatus for detection of a biomarker by alternating current electrokinetics |
| CA2988297A1 (en) | 2016-12-28 | 2018-06-28 | University Of Tennessee Research Foundation | Methods for detecting a biomarker by alternating current electrokinetics |
| WO2018170436A1 (en) | 2017-03-16 | 2018-09-20 | Jacobs Farm Del Cabo | Basil with high tolerance to downy mildew |
| US11917978B2 (en) | 2017-09-21 | 2024-03-05 | The Conard Pyle Company | Miniature rose plant named ‘meibenbino’ |
| US11252928B2 (en) | 2017-09-21 | 2022-02-22 | The Condard-Pyle Company | Miniature rose plant named ‘Meibenbino’ |
| US20200348300A1 (en) * | 2018-01-18 | 2020-11-05 | The Penn State Research Foundation | Mycobacterium avium subspecies paratuberculosis immunodiagnostic antigens, methods, and kits comprising same |
| US11944063B2 (en) | 2020-09-30 | 2024-04-02 | Spring Meadow Nursery, Inc. | Hydrangea ‘SMNHPH’ |
| EP3984355B1 (en) | 2020-10-16 | 2024-05-15 | Klemm & Sohn GmbH & Co. KG | Double-flowering dwarf calibrachoa |
| US11155884B1 (en) | 2020-10-16 | 2021-10-26 | Klemm & Sohn Gmbh & Co. Kg | Double-flowering dwarf Calibrachoa |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4139840B4 (de) * | 1990-12-04 | 2005-06-02 | Quidel Corp., San Diego | Antigen-Zubereitung zum Nachweis von H. pylori |
| US6592877B1 (en) * | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| EP1803730A1 (en) | 2000-04-12 | 2007-07-04 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| JP3864230B2 (ja) * | 2003-09-26 | 2006-12-27 | 独立行政法人農業・食品産業技術総合研究機構 | ヨーネ菌抗原タンパク質、該タンパク質をコードする遺伝子、及び該タンパク質を用いるヨーネ病の診断方法 |
-
2005
- 2005-09-06 US US11/220,156 patent/US7713715B2/en not_active Expired - Fee Related
-
2006
- 2006-09-05 CA CA2621485A patent/CA2621485C/en not_active Expired - Fee Related
- 2006-09-05 JP JP2008530117A patent/JP2009507243A/ja active Pending
- 2006-09-05 WO PCT/US2006/034287 patent/WO2007030391A2/en not_active Ceased
- 2006-09-05 BR BRPI0615678-9A patent/BRPI0615678A2/pt not_active IP Right Cessation
- 2006-09-05 EP EP06814088A patent/EP1928614A4/en not_active Withdrawn
- 2006-09-05 AU AU2006287702A patent/AU2006287702A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7713715B2 (en) | 2010-05-11 |
| WO2007030391A3 (en) | 2007-09-20 |
| CA2621485C (en) | 2013-01-15 |
| JP2009507243A (ja) | 2009-02-19 |
| EP1928614A4 (en) | 2009-06-17 |
| EP1928614A2 (en) | 2008-06-11 |
| BRPI0615678A2 (pt) | 2011-05-24 |
| WO2007030391A2 (en) | 2007-03-15 |
| US20070054334A1 (en) | 2007-03-08 |
| CA2621485A1 (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2621485C (en) | Method for diagnosing infections utilizing surface antigens obtained without disrupting cells | |
| KR102651297B1 (ko) | 미생물 항원의 회수법 | |
| DK174032B1 (da) | Sæt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler | |
| KR20170023554A (ko) | 브루셀라 캐니스 항원의 제조 방법 | |
| US7422869B2 (en) | Method for diagnosing infectious diseases | |
| WO2008108510A1 (en) | Diagnostic kit for leptospirosis | |
| Hajikolaei et al. | Comparison of leptospiral infection in the horse and donkey | |
| WO2000073492A1 (en) | Rapid immunoassay for cariogenic bacteria | |
| WO2008030865A1 (en) | Assay for antibodies to mycobacterium paratuberculosis | |
| JP4268358B2 (ja) | 抗体および免疫学的測定方法 | |
| EP1700128B1 (fr) | Methode de diagnostic serologique et determination de statut vaccinal comprenant differents controles | |
| Rhawy | Rapid diagnosis of the most common causes of abortion in Awassi ewes in Nineveh Governorate, Iraq | |
| JP2000088854A (ja) | 微生物（細菌，眞菌，ウイルス，産生物質）の高感度な免疫 学的検出測定法および定量方法 | |
| Inzana et al. | Commercial methods in clinical veterinary microbiology | |
| US20080038758A1 (en) | Diagnostic Method for Paratuberculosis | |
| US20230221319A1 (en) | A Method, A System, An Article, A Kit And Use Thereof For Biomolecule, Bioorganelle, Bioparticle, Cell And Microorganism Detection | |
| KR20180006516A (ko) | Igm 반정량적 렙토스피라증 진단 키트 | |
| Gurung et al. | Development of 316v antibody enzyme-linked immunosorbent assay for detection of paratuberculosis in sheep | |
| Graves et al. | Laboratory diagnosis of rickettsial infection | |
| US8642275B2 (en) | Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method | |
| US20130236915A1 (en) | Method of inspecting periodontal disease causing bacteria using outer membrane vesicle and measuring appliance of the same | |
| Rao et al. | A Review on History and Detection of Salmonella Enterica Typhi | |
| CA2576726A1 (fr) | Methode et trousse de determination du statut vaccinal de personnes | |
| Gamage et al. | LABORATORY DIAGNOSIS OF RODENT-BORNE ZOONOSES: LEPTOSPIROSIS IN SRI LANKA | |
| Tuntasuvan et al. | Determination of the Trypanosoma congolense and the Trypanosoma evansi antibodies detection ELISA for the diagnosis of surra in cattle in Thailand |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |